Results 121 to 130 of about 38,639 (213)

Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposure. [PDF]

Lancet Reg Health Southeast Asia, 2023
Kang G, Lakhkar A, Bhamare C, Dharmadhikari A, Narwadkar J, Kanujia A, Kapse D, Gunale B, Poonawalla CS, Kulkarni PS.   +9 more
europepmc   +1 more source

Active Surveillance on Safety and Compliance of Freeze-dried Human Rabies Vaccine (Vero Cell) - Jiangsu Province, China, 2023-2024. [PDF]

China CDC Wkly
Chen Y, Wei M, Xu X, Shi Y, Zhang S, Wang C, Liang Q, Guo X, Pan H.   +8 more
europepmc   +1 more source

Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine. [PDF]

Hum Vaccin Immunother, 2022
Agarwal A, Mathur SB.
europepmc   +1 more source

Oxidized Mannan: A Novel Adjuvant Candidate for Enhancing Immune Responses in Veterinary Rabies Vaccine. [PDF]

Chonnam Med J
Mardani R, Bahmanje A, Kazeroni YC, Khoshroo F, Roshanaie B, Sadeghche T, Pajaie K, Hosseini SN, Doroud D, Shahali M.   +9 more
europepmc   +1 more source

Immune Response of Inactivated Rabies Vaccine Inoculated via Intraperitoneal, Intramuscular, Subcutaneous and Needle-Free Injection Technology-Based Intradermal Routes in Mice. [PDF]

Int J Mol Sci, 2023
Zhao H, Li P, Bian L, Zhang W, Jiang C, Chen Y, Kong W, Zhang Y.   +7 more
europepmc   +1 more source

Noninferiority Study of Purified Vero Rabies Vaccine-Serum Free in 3-dose and 2-dose Preexposure Prophylaxis Regimens in Comparison With Licensed Rabies Vaccines. [PDF]

Clin Infect Dis
Chokephaibulkit K, Huoi C, Tantawichien T, Mootsikapun P, Kosalaraksa P, Kiertiburanakul S, Ratanasuwan W, Vangelisti M, Laot T, Huang Y, Petit C, Pineda-Peña AC, Frago C.   +12 more
europepmc   +1 more source

An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs. [PDF]

Virol J, 2022
Li J, Liu Q, Liu J, Wu X, Lei Y, Li S, Zhao D, Li Z, Luo L, Peng S, Ou Y, Yang H, Jin J, Li Y, Peng Y.   +14 more
europepmc   +1 more source

A randomized, non-inferiority phase III clinical trial of immunogenicity and safety of 5-dose and 4-dose schedules of a freeze-dried human rabies vaccine (MRC-5 cells) in participants aged 10-60. [PDF]

BMC Infect Dis
Zhao D, Zhao J, Chen X, Yuan L, Wang P, Shi L, Wang Y, Li J, Zhou L, Wu X, Yang S, Gao L.   +11 more
europepmc   +1 more source

A recombinant rabies vaccine that prevents viral shedding in rabid common vampire bats (Desmodus rotundus). [PDF]

PLoS Negl Trop Dis, 2022
Cárdenas-Canales EM, Velasco-Villa A, Ellison JA, Satheshkumar PS, Osorio JE, Rocke TE.   +5 more
europepmc   +1 more source

Availability of anti-rabies vaccine and rabies immunoglobulin in Indian health facilities: a nationwide cross-sectional health facility survey. [PDF]

Lancet Reg Health Southeast Asia
Krishna NS, Vivian Thangaraj JW, Devika S, Sasi A, Egambaram S, Rani DS, Khan SA, Delli A, Srivastava AK, Mishra A, Shrinivasa B, Pandiyan C, Gour D, Purakayastha DR, Verma N, Sharma P, Soni RK, Ramasamy S, Mohandas K S, Baidya S, Rehman T, Yeldandi VV, Singh A, Sreedevi A, Tandale BV, Durairajan C, Mahajan H, Jain K, Reddy MM, Toppo M, Solanki NV, Ghosh P, Vyas S, Das S, Palo SK, Prasanth V, Ali A, Bathin VG, Sahu DK, Rani GPS, Madhukar M, Zaman K, Pandey K, Chander MP, Kant R, Varkey RA, Pati S, Agarwal S, Panwar S, Menon VB, Vaman RS, Velayudhan A, Joy S, Rahi M, Murhekar MV.   +54 more
europepmc   +1 more source